批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2023/09/26 |
SUPPL-41(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/03/31 |
SUPPL-38(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/08/29 |
SUPPL-35(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2013/05/02 |
SUPPL-34(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2012/08/30 |
SUPPL-30(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2009/10/08 |
SUPPL-29(补充) |
Approval |
Labeling |
901 REQUIRED
|
|
|
2009/09/24 |
SUPPL-28(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2007/08/01 |
SUPPL-26(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/03/06 |
SUPPL-25(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2005/07/19 |
SUPPL-24(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2004/02/06 |
SUPPL-21(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2004/02/06 |
SUPPL-20(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/06/12 |
SUPPL-18(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/06/12 |
SUPPL-14(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/04/12 |
SUPPL-17(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2002/02/22 |
SUPPL-16(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2001/05/03 |
SUPPL-15(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2000/11/29 |
SUPPL-13(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2000/10/04 |
SUPPL-11(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1999/12/21 |
SUPPL-12(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1999/05/13 |
SUPPL-10(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1998/07/27 |
SUPPL-7(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1998/07/24 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1998/03/30 |
SUPPL-5(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1998/01/30 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1997/06/19 |
SUPPL-4(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1997/03/05 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1995/07/14 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:CYCLOSPORINE 剂型/给药途径:SOLUTION;ORAL 规格:100MG/ML 治疗等效代码:AB1
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
050716 |
001 |
NDA |
NEORAL |
CYCLOSPORINE |
SOLUTION;ORAL |
100MG/ML |
Prescription |
Yes |
Yes |
AB1 |
1995/07/14
|
NOVARTIS |
065025 |
001 |
ANDA |
CYCLOSPORINE |
CYCLOSPORINE |
SOLUTION;ORAL |
100MG/ML |
Prescription |
No |
No |
AB1 |
2000/03/03
|
ABBVIE |
065078 |
001 |
ANDA |
CYCLOSPORINE |
CYCLOSPORINE |
SOLUTION;ORAL |
100MG/ML |
Prescription |
No |
No |
AB1 |
2005/03/25
|
IVAX SUB TEVA PHARMS |